期刊文献+

活体成像系统检测携荧光素酶增殖缺陷型腺病毒在小鼠体内的表达和分布 被引量:2

In vivo imaging system in detecting expression and distribution of replication-deficient adenovirus carrying luciferase in mice
原文传递
导出
摘要 目的:研究携带荧光素酶的增殖缺陷型腺病毒(Ad-luciferase,Ad-Luci)经不同途径注射后小鼠体内荧光素酶的表达和分布,为肿瘤的腺病毒载体基因治疗提供参考。方法:建立人胰腺癌PANC-1细胞裸鼠移植瘤模型,Ad-Luci病毒单次或多次瘤体内注射,或者肌内、尾静脉和腹腔注射Ad-Luci病毒至正常小鼠,采用IVIS Lumina活体成像系统观察荧光素酶在小鼠体内的分布和表达,并观察Ad-Luci病毒的毒性作用。结果:单次瘤内注射Ad-Luci荧光素酶在瘤内持续表达15 d,多次瘤内注射后表达时间更长。肌内注射组荧光素酶随时间延长表达减弱,注射后48 h无荧光素酶表达。尾静脉注射组荧光素酶大部分聚集在肝脏,注射后18 d仍有表达。腹腔注射组4 h后可见荧光素酶的表达,但7 d后无表达。Ad-Luci各注射组小鼠均未出现明显的毒性反应。结论:腺病毒携带外源基因经瘤内注射可在瘤内表达较长时间,多次注射可延长表达时间;经尾静脉注射后主要聚集在肝脏,且表达时间较长。 Objective: To study the expression of luciferase in mice delivered by replication-deficient adenovirus carrying luciferase(Ad-luciferase,Ad-Luci) through different injection routes,so at to provide information for adenovirus-mediated tumor gene therapy.Methods: Nude mouse model bearing human pancreatic cancer PANC-1 cells was established and Ad-Luci was administered into transplanted tumors with single or multiple intratumoral injections.Ad-Luci was also administered into normal mice through intramuscular,intravenous and intraperitoneal injections.The distribution and expression of luciferase in mice were monitored by in vivo IVIS Lumina imaging system and the toxicity of Ad-Luci was also studied.Results: Single intratumoral injection of Ad-Luci resulted in continuous luciferase expression for at least 15 d,while multiple injections resulted in even longer expression.Intramuscular injection of Ad-Luci gave a weaker and shorter duration of luciferase expression for no longer than 48 h.The majority of Ad-Luci injected through tail-vein homed to liver and expressed luciferase for at least 18 d.Expression of luciferase by intraperitoneal injection decreased with time-lapse and lasted for about 7 d.No significant toxic reactions were observed in all groups during the study.Conclusion: Intratumoral injection of adenovirus carrying exogenous gene gives a continuous expression of gene for a long duration,while multiple injections result in even longer expression;liver is the main target organ after tail intravenous administration and provides long expression duration.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第4期389-393,共5页 Chinese Journal of Cancer Biotherapy
基金 国家高科技研究发展计划(863计划)资助项目(No.2007AA021001) 国家自然科学基金资助项目(No.30772527)~~
关键词 腺病毒载体 胰腺癌 荧光素酶 活体成像系统 基因治疗 adenovirus vector pancreatic cancer luciterase in vivo imaging system gene therapy
  • 相关文献

参考文献8

  • 1Mezzanotte L, Que I, Kaijzel E, et al. Sensitive dual color in vivo biol imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase [ J ]. PLoS One 2011, 6(4) : e19277.
  • 2Wang Y, Ma L, Wang S, et al. Assessment of CAR- or CD46-dependent adenoviral vector-mediated TRAIL gene therapy in clinical adenocareinoma lung cancer cells [ J ]. Oneology, 2009, 77 (6) : 366-377.
  • 3孙宝昌,靳宝锋,侗冬青,梁冰,李卫华,周涛.荧光素酶标记的BEL-7405细胞体内外成像及肿瘤动物模型建立[J].中国比较医学杂志,2008,18(1):1-4. 被引量:9
  • 4Wang J, Thorson L, Stokes RW, et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis [ J]. J Immunol, 2004, 173(10): 6357-6365.
  • 5Hoist P J, Orskov C, Thomsen AR, et al. Quality of the transgenespecific CD8^+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination [J]. J Immunol, 2010, 184(8) : 4431-4439.
  • 6Liu X, Li J, Tian Y, et al. Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide [J]. Hum Gene Ther, 2010, 21 (2): 157-170.
  • 7刘思景,郭伟韬,王辉.腺病毒载体的研究新进展[J].现代中西医结合杂志,2010,19(13):1669-1670. 被引量:6
  • 8张怡,韩彧,赵春林.活体动物体内光学成像技术的研究进展[J].生命科学,2006,18(1):25-30. 被引量:21

二级参考文献62

  • 1张鹏,李涛,郎锦义.人生存素T34A重组腺病毒载体的构建、鉴定和体外表达[J].华西医学,2008,23(6):1362-1364. 被引量:1
  • 2Contag P R, Olomu I N, Stenvenson D K, et al. Bioluminescent indicators in living mammals. Nat Med,1998, 4(2):245-247.
  • 3Ntziachristos V, Ripoll J, Wang L V, et al. Looking and listenting to light: the evolution of whole-body photonic imaging. Nat Biotechnol, 2005, 23(3): 313-320.
  • 4Iyer M, Berenji M, Templeton N S, et al. Noninvasive imaging of cationic lipid-mediated delivery of optical and PET reporter genes in living mice. Mol Ther, 2002, 6(4): 555-562.
  • 5Maggi A, Ciana P. Reporter mice and drug discovery and development. Nat Rev Drug Discov, 2005, 4(3): 249-255.
  • 6Rice B W, Cable M D, Nelson M B. In vivo imaging of light-emitting probes. J Biomed Opt, 2001, 6(4):432-440.
  • 7Edinger M, Cao Y A, Verneris M R, et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood, 2003,101 (2):640-648.
  • 8Minn A J, Kang Y, Serganova I, et al. Distinct organ-specific metastalic potential of individual breast cancer cells and primary tumors. J Clin Invest, 2005, 115:44-55.
  • 9Chen X Y, Conti P S, Moats R A. In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts.Cancer Res, 2004, 64:8009-8014.
  • 10Gao X H, Cui Y Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots.Nat Biotechnol, 2004, 22:969-976.

共引文献32

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部